98%
921
2 minutes
20
Introduction: Advancements in stent materials and designs are aimed at improving stent-related morbidities, lower urinary tract symptoms (LUTSs), pain, and compromised quality of life (QoL). Various stent materials and coatings have been investigated for their impact on stent-related symptoms. This prospective randomized study aimed to compare urinary symptoms and QoL in patients with polyurethane double J (DJ) stents, with or without hydrophilic polyvinylpyrrolidone coating.
Materials And Methods: Sixty adult patients undergoing endourological procedures and DJ stent placement were randomized into two groups in 2:1 ratio. In 20 patients, polyurethane stents with hydrophilic coating and in 40 patients, stents without hydrophilic coating were placed. In all patients, a stent of 5F diameter and 26 cm length was used. Urinary symptoms, pain, and QoL were assessed at the time of stent removal, i.e., at 3-4 weeks using the validated ureteral stent symptom questionnaire (USSQ).
Results: The demographic data were comparable in both groups. Patients with hydrophilic stents reported significantly fewer urinary symptoms (mean score 10.75 vs. 15.28, < 0.001), lower pain scores (1.50 vs. 3.18, < 0.001), and better QoL scores (3.0 vs. 5.23, < 0.001). Symptoms such as frequency, nocturia, urgency, and burning micturition were notably reduced in the hydrophilic group. In addition, 60% of patients in the hydrophilic group reported no pain compared to only 7.5% in the nonhydrophilic group ( < 0.001).
Conclusion: Hydrophilic-coated DJ stents significantly alleviate LUTS and improve QoL, warranting further large-scale research to validate these findings. These findings align with previous studies suggesting that hydrophilic coatings improve stent-related outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312835 | PMC |
http://dx.doi.org/10.4103/iju.iju_487_24 | DOI Listing |
PLoS One
September 2025
Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
There is a lack of longitudinal data on type 2 diabetes (T2D) in low- and middle-income countries. We leveraged the electronic health records (EHR) system of a publicly funded academic institution to establish a retrospective cohort with longitudinal data to facilitate benchmarking, surveillance, and resource planning of a multi-ethnic T2D population in Malaysia. This cohort included 15,702 adults aged ≥ 18 years with T2D who received outpatient care (January 2002-December 2020) from Universiti Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
View Article and Find Full Text PDFJAAPA
September 2025
At the time this article was written, Mollie Francis, Michaela Thielen, and Cailin Austin were PA students at Mayo Clinic in Rochester, MN. Now, Mollie Francis works as a hospitalist PA at Regions Hospital in St. Paul, MN; Michaela Thielen as a dermatology PA at OakLeaf Clinics Dermatology in Chippe
Pelvic floor disorders are a wide-ranging group of conditions arising due to abnormalities of the musculature of the pelvic floor. These conditions can include constipation, pelvic pain, urinary incontinence, and dyspareunia. This article first provides an overview of key anatomy of the pelvic floor muscles before discussing pelvic floor physical therapy (PFPT), highlighting the goals of treatment and tactics used by physical therapists to achieve these goals.
View Article and Find Full Text PDFPediatr Nephrol
September 2025
Pediatric Urology Unit, "Santobono-Pausilipon" Children's Hospital, Naples, Italy.
Voiding cystourethrography (VCUG) is indicated for evaluating the anatomy of the urethra and bladder. It is primarily used to diagnose vesicoureteral reflux (VUR) and posterior urethral valves (PUV), especially in cases of febrile urinary tract infections (UTIs), significant ureteral dilation on ultrasound, and-in continent children-urinary symptoms suggestive of infravesical obstruction. VCUG exposes children to a non-negligible dose of radiation and requires urethral catheterization, which can be painful-particularly in males-and carries a low but present risk of post-procedural UTI.
View Article and Find Full Text PDFClin Pharmacol Drug Dev
September 2025
Phase I Clinical Research Centre, Wuhan Pulmonary Hospital, Wuhan, China.
Tamsulosin is a highly selective α1A adrenergic receptor antagonist that can relax smooth muscles in the urethra, bladder neck, and prostate and improve urinary disorders. It is therefore widely used to treat lower urinary tract symptoms caused by benign prostatic hyperplasia. The aim of this study is to evaluate the pharmacokinetic (PK) characteristics and bioequivalence of 2 different formulations (tamsulosin sustained-release tablets and tamsulosin sustained-release capsules) in healthy Chinese subjects.
View Article and Find Full Text PDFNMR Biomed
October 2025
High-Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
The human kidneys play a pivotal role in regulating blood pressure, water, and salt homeostasis, but assessment of renal function typically requires invasive methods. Deuterium metabolic imaging (DMI) is a novel, noninvasive technique for mapping tissue-specific uptake and metabolism of deuterium-labeled tracers. This study evaluates the feasibility of renal DMI at 7-Tesla (7T) to track deuterium-labeled tracers with high spatial and temporal resolution, aiming to establish a foundation for potential clinical applications in the noninvasive investigation of renal physiology and pathophysiology.
View Article and Find Full Text PDF